본문 바로가기
KERD
논문KCI 등재

Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

The objective of this article is to detail the 2017 tumor-node-metastasis (TNM) staging criteria for thyroid cancer. The literature presents only few contributions, with controversial results, about comparison between previous and the new TNM systems. The 2017 TNM classification categorizes either thyroid carcinomas only limited to the gland either carcinomas macroscopically infiltrating into defined anatomical structures. The “minimal extrathyroid spread” into the perithyroidal adipose tissue no longer appears as a classification parameter in the new TNM. In the present paper is discussed for the pT categories pT1a, pT1b, pT2, and pT3a. In detail, the T-categories pT1a, pT1b, pT2, and pT3a are each subdivided into true thyroid-restricted carcinomas (pT1a1, pT1b1, pT2a1, and pT3a1) and “minimal extrathyroid proliferation” carcinomas (pT1a2, pT1b2, pT2b, and pT3a2). As a basis, a strict definition of the “minimal extrathyroid propagation” of thyroid carcinomas is essential. Although the suggestion made with the additional substrate characterization makes the work of the pathologist more intricate in daily use, standardized fundamentals for demonstrating or excluding the prognostic and therapeutic relevance concerning a “minimal extrathyroid extension” in thyroid carcinoma appear to be necessary.

Abstract

The objective of this article is to detail the 2017 tumor-node-metastasis (TNM) staging criteria for thyroid cancer. The literature presents only few contributions, with controversial results, about comparison between previous and the new TNM systems. The 2017 TNM classification categorizes either thyroid carcinomas only limited to the gland either carcinomas macroscopically infiltrating into defined anatomical structures. The “minimal extrathyroid spread” into the perithyroidal adipose tissue no longer appears as a classification parameter in the new TNM. In the present paper is discussed for the pT categories pT1a, pT1b, pT2, and pT3a. In detail, the T-categories pT1a, pT1b, pT2, and pT3a are each subdivided into true thyroid-restricted carcinomas (pT1a1, pT1b1, pT2a1, and pT3a1) and “minimal extrathyroid proliferation” carcinomas (pT1a2, pT1b2, pT2b, and pT3a2). As a basis, a strict definition of the “minimal extrathyroid propagation” of thyroid carcinomas is essential. Although the suggestion made with the additional substrate characterization makes the work of the pathologist more intricate in daily use, standardized fundamentals for demonstrating or excluding the prognostic and therapeutic relevance concerning a “minimal extrathyroid extension” in thyroid carcinoma appear to be necessary.

참고문헌 (44)

  1. Rausei S, "Locally advanced gastric cancer: a new definition to standardise", J Clin Pathol, 66, pp.164~165 (2013)[DOI]
  2. Rausei S, "Evaluation of the Seventh American Joint Committee on Cancer", International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification, 2011, pp.117, 2823~2824
  3. Rausei S, "How does the 7th TNM edition fit in gastric cancer management?", Ann Surg Oncol, 18, pp.1219~1221 (2011)[DOI]
  4. Pellegriti G, "Papillary thyroid cancer incidence in the volcanic area of Sicily", J Natl Cancer Inst, 101, pp.1575~1583 (2009)[DOI]
  5. Ieni A, "One-third of an archivial series of papillary thyroid cancer (years 2007-2015) has coexistent chronic lymphocytic thyroiditis, which is associated with a more favorable tumor-node-metastasis staging", Front Endocrinol (Lausanne), 8, pp.337~ (2017)[DOI]
  6. Amin MB, "AJCC Cancer Staging Manual. 8th ed" (2017), Springer
  7. Sobin LH, "TNM Classification of Malignant Tumours. 6th ed" (2002), Wiley-Liss
  8. Schmid KW, "Die missgluckte klassifikation", Pathologe, 24, pp.338~ (2003)[DOI]
  9. Sobin LH, "TNM Classification of Malignant Tumours. 5th ed" (1997), Wiley-Liss
  10. Wittekind C, "TNM Supplement: a Commentary on Uniform Use. 3rd ed" (2003), Wiley-Liss
  11. Sobin LH, "TNM Classification of Malignant Tumours. 7th ed" (2010), Wiley-Blackwell
  12. Jin BJ, "Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma", Oral Oncol, 51, pp.759~763 (2015)[DOI]
  13. Woo CG, "Clinicopathological significance of minimal extrathyroid extension in solitary papillary thyroid carcinomas", Ann Surg Oncol, 22(Suppl 3), pp.S728~S733 (2015)
  14. Shin JH, "Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma", Int J Surg, 11, pp.944~947 (2013)[DOI]
  15. Hotomi M, "A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis", World J Surg, 36, pp.1231~1240 (2012)[DOI]
  16. Moon HJ, "Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?", Ann Surg Oncol, 18, pp.1916~1923 (2011)[DOI]
  17. Synoracki S, "Definition of R1 resection in thyroid carcinoma", Chirurg, 88, pp.740~747 (2017)[DOI]
  18. Clain JB, "Extrathyroidal extension predicts extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management", Thyroid, 24, pp.951~957 (2014)[DOI]
  19. Machens A, "Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: different biology", Eur J Surg Oncol, 41, pp.766~772 (2015)[DOI]
  20. Roh JL, "Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma", J Surg Oncol, 116, pp.450~458 (2017)[DOI]
  21. Federative Committee on Anatomical Terminology (DE), "Terminologia Anatomica: International Anatomical Terminology" (1998), Thieme
  22. Randolph G, "Surgery of the Thyroid and Parathyroid Glands. 2nd ed", pp.2013, Saunders
  23. Bliss RD, "Surgeon's approach to the thyroid gland: surgical anatomy and the importance of technique", World J Surg, 24, pp.891~897 (2000)[DOI]
  24. Dralle H, "Endokrine chirurgie by Schattauer GmbH", Holderlinstrafe, 3, pp.70174~ (2014)
  25. Dionigi G, "Minimally invasive follicular thyroid cancer (MIFTC)--a consensus report of the European Society of Endocrine Surgeons (ESES)", Langenbecks Arch Surg, 399, pp.165~184 (2014)[DOI]
  26. Schmid KW, "Proposal for an extended pTNM classification of thyroid carcinoma: commentary on deficits of the 8th edition of the TNM classification (German version)", Pathologe, 39, pp.49~56 (2018)[DOI]
  27. Tiedje V, "Molecular pathogenesis of thyroid tumors", Dtsch Med Wochenschr, 140, pp.578~582 (2015)[DOI]
  28. Mete O, "Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension", Ann Surg Oncol, 17, pp.386~391 (2010)[DOI]
  29. Al-Qurayshi Z, "Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer", Endocr Relat Cancer, 24, pp.221~226 (2017)[DOI]
  30. Ito Y, "Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival", World J Surg, 30, pp.780~786 (2006)[DOI]
  31. Radowsky JS, "Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome", Thyroid, 24, pp.241~244 (2014)[DOI]
  32. Brierley JD, "TNM Classification of Malignant Tumours. 8th ed" (2017), John Wiley & Sons
  33. Campenni A, "Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer?", Thyroid, 24, pp.1607~1611 (2014)[DOI]
  34. Schmid KW, "Pathologie: Urogenitale und Endokrine Organe, Gelenke und Skelett", pp.631~712 (2016), Springer
  35. Dralle H, "German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors", Langenbecks Arch Surg, 398, pp.347~375 (2013)[DOI]
  36. Su HK, "Inter-observer variation in the pathologic identification of minimal extrathyroidal extension in papillary thyroid carcinoma", Thyroid, 26, pp.512~517 (2016)[DOI]
  37. Park S, "Association between screening and the thyroid cancer epidemic in South Korea: evidence from a nationwide study", BMJ, 355, pp.i5745~ (2016)
  38. Davies L, "Current thyroid cancer trends in the United States", JAMA Otolaryngol Head Neck Surg, 140, pp.317~322 (2014)[DOI]
  39. Rosai J. LiVolsi VA, "Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal", Int J Surg Pathol, 11, pp.249~251 (2003)[DOI]
  40. Lloyd RV, "WHO Classification of Tumours of Endocrine Organs", pp.65~143 (2017), International Agency for Research on Cancer
  41. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19, pp.1167~1214 (2009)[DOI]
  42. Musholt TJ, "German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease", Langenbecks Arch Surg, 396, pp.639~649 (2011)[DOI]
  43. Goffredo P, "Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients", Ann Surg Oncol, 20, pp.767~772 (2013)[DOI]
  44. Nikiforov YE, "Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors", JAMA Oncol, 2, pp.1023~1029 (2016)[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (8건)